Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

3755studies shown

Showing 1-12 of 3,755

Behavioral study icon

RecruitingNCT07494955

"Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section"

This summary needs review. Please check the official study record and contact the research team for details.

In Erzurum

AnxietyBehavioralFrom 18 Years to 45 Years

Countries: Türkiye
Sponsor: Aysenur Dostbil
Condition: Anxiety

Other study type icon

RecruitingNCT07444697

"Erectile Function After PCI in MI and Non-MI Patients"

This summary needs review. Please check the official study record and contact the research team for details.

In Kirikkale

Anxiety, DepressionObservationalFrom 30 Years to 75 Years

Countries: Türkiye
Sponsor: Kırıkkale University
Condition: Anxiety, Depression

Drug study icon

RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto

SchizophreniaDrugOver 18 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Schizophrenia

Other study type icon

RecruitingNCT06899490

"Machine Learning Analysis of Lingual Colorimetry and MADRS Anxiety-Depression Score in Acupuncture Patients"

This summary needs review. Please check the official study record and contact the research team for details.

In Narbonne

Anxiety, DepressionObservationalOver 18 Years

Countries: France
Sponsor: Dr Benoit Bataille
Condition: Anxiety, Depression

Behavioral study icon

RecruitingNCT05965622

(Cost)-Effectiveness of ABFT for Suicidal Youth.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tongeren

SuicidalityBehavioralFrom 18 Years to 25 Years

Countries: Belgium, Netherlands
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition: Suicidality

Drug study icon

RecruitingNCT05703685

PET brain imaging study for depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In Bethesda

DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression

Drug study icon

RecruitingNCT05011760

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

The registry lists this study as recruiting. Study locations are listed in the United States.

In Pittsburgh

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Rajesh Narendran
Condition: Addiction

Device study icon

RecruitingNCT05680220

40 Hz Light Neurostimulation for people with Depression (FELIX)

This summary needs review. Please check the official study record and contact the research team for details.

In Copenhagen

DepressionDeviceFrom 18 Years to 75 Years

Countries: Denmark
Sponsor: Klaus Martiny
Condition: Depression

Device study icon

RecruitingNCT06907420

40 Hz Visual Stimulation as an Intervention in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Munich

SchizophreniaDeviceOver 18 Years

Countries: Germany
Sponsor: Technical University of Munich
Condition: Schizophrenia

Drug study icon

RecruitingNCT05452772

5-HT2A Agonist Psilocybin in the Treatment of Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Birmingham

AddictionDrugOver 21 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Addiction

Drug study icon

RecruitingNCT05895747

5-HTP and Creatine for Depression R33 Phase

This summary needs review. Please check the official study record and contact the research team for details.

In Salt Lake City

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Utah
Condition: Depression

Drug study icon

RecruitingNCT07369154

52-week Open Label Safety-Tolerability Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chandler

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: LB Pharmaceuticals Inc.
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.